|
|
| Titles |
1997 Der Nervenarzt Gabitril |
| Related Item |
|
| Genre |
medicine |
| Genre |
medicines (psychiatric) |
| Identifier |
DERN 246 |
| Note |
Epilepsy needs more engagement. Progress has a new size. Proven Therapy Principle. Targeted strengthening of the major inhibitory neurotransmitter GABA.. Innovative Mechanisms: Selective Inhibition of GABA uptake. Compelling benefit/ risk profile. Paritcularlly effective for focal epilepsies. Particularly well tolerated. No clinically relevant interactions observed. No loss of activity. No increased risk of psychosis. |
| Abstract |
Iagabin, Novocare, A small tablet is present above the left hand side where all of the clinical efficacy claims are made. The fine print is featured in what looks like a newspaper article. The logo for the drug is the central image. |
